Myomo stock

Myomo Inc. is an attractive microcap company from a long-term investment standpoint. The recent patent approvals in China and Hong Kong only strengthen the long-term outlook.

The latest closing stock price for Myomo as of May 06, 2024 is 3.94. The all-time high Myomo stock closing price was 579.30 on June 19, 2017. The Myomo 52-week high stock price is 5.58, which is 41.6% above the current share price. The Myomo 52-week low stock price is 0.37, which is 90.6% below the current share price.The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used to help inform investors when researching potential investment opportunities. Myomo Inc ...Track Myomo Inc (MYO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors17 Sept 2020 ... Only 3.6 million Outstanding Shares. Next big catalyst will be Q3 ER in early November and even without Medicare/Medicaid approval they were ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...

The latest closing stock price for Myomo as of May 06, 2024 is 3.94. The all-time high Myomo stock closing price was 579.30 on June 19, 2017. The Myomo 52-week high stock price is 5.58, which is 41.6% above the current share price. The Myomo 52-week low stock price is 0.37, which is 90.6% below the current share price.04:00 PM EDT May 13, 2024. $3.64. -0.19. ( -4.96 % ) ISIN. US62857J2015. Shares in Issue (As of November 07, 2023) 28,814,637. Best Bid.Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.. Total and product revenue was $3.8 million, up 9%; Revenue units were 91, up 14%; MyoPro ® orders and …Dec 31, 2016 · Paul Gudonis. myomo.com. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient ... Myomo - MYO - Stock Price Today - Zacks. Myomo (MYO) (Delayed Data from AMEX) $3.93 USD. +0.31 (8.56%) Updated May 8, 2024 04:00 PM ET. After-Market: $3.95 +0.02 (0.51%) 7:54 PM ET. Add to...Myomo Inc. Common Stock (MYO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.MYO stock results show that Myomo met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI …The stock photos that come with your Chromecast are beautiful and all, but if you want to switch things up, you can customize it a bit more to your liking. All you need is the Goog...

Myomo Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MYO updated stock price target summary.Mar 24, 2021 · Myomo is a small-cap medical wearable company with a clear product portfolio, a clear strategy, and big potential. ... Mar. 24, 2021 2:26 PM ET Myomo, Inc. (MYO) Stock 23 Comments 7 Likes ... Find the latest dividend history for Myomo Inc. Common Stock (MYO) at Nasdaq.com.Myomo Stock Earnings. The value each MYO share was expected to gain vs. the value that each MYO share actually gained. Myomo ( MYO) reported Q4 2023 earnings per share (EPS) of -$0.07, missing estimates of -$0.06 by 21.57%. In the same quarter last year, Myomo 's earnings per share (EPS) was -$0.29. Myomo is expected …According to the issued ratings of 2 analysts in the last year, the consensus rating for Myomo stock is Buy based on the current 2 buy ratings for MYO. The average twelve-month price prediction for Myomo is $6.50 with a high price target of $6.50 and a low price target of $6.50. Learn more on MYO's analyst rating history.

Csc service works.

(NYSEMKT: MYO) Myomo stock price per share is $2.70 today (as of Apr 15, 2024).The Myomo, Inc stock price gained 8.56% on the last trading day (Wednesday, 8th May 2024), rising from $3.62 to $3.93.During the last trading day the stock fluctuated 12.64% from a day low at $3.52 to a day high of $3.97.The price has been going up and down for this period, and there has been a 14.24% gain for the last 2 weeks.Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript. Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock …Open 3.8900. Bid 3.6000 x 2900. Ask 3.6700 x 1000. Day's Range 3.6200 - 3.9927. 52 Week Range 0.3710 - 5.5800. Volume 89,060. Avg. Volume 281,275. Market Cap …The stock split of Myomo Inc occurred on January 31, 2020 on a 1-for-30 basis, meaning that for 30 shares of MYO owned pre-split, shareholders then owned 1 share. This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes …It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...

Myomo (MYO) shares are trading higher on Tuesday after the company's disclosure on Sept. 11 that director Morris Milton Mayo bought 15K shares in the company at $1.06 on SeptA high-level overview of Myomo, Inc. (MYO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment ...Press Release. Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. BOSTON (January 17, 2024) ─ Myomo, Inc. (NYSE American: MYO) (“ Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper …Myomo (MYO) shares are trading higher on Tuesday after the company's disclosure on Sept. 11 that director Morris Milton Mayo bought 15K shares in the company at $1.06 on SeptJan 30, 2020 · Myomo’s common stock will continue to trade on the NYSE American under the symbol “MYO,” although a new CUSIP number (62857J 201) has been assigned to it as a result of the reverse stock split. Myomo Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MYO updated stock price target summary.Myomo is a small-cap medical wearable company with a clear product portfolio, a clear strategy, and big potential. ... Mar. 24, 2021 2:26 PM ET Myomo, Inc. (MYO) Stock 23 Comments 7 Likes ...Myomo (MYO) shares are trading higher on Tuesday after the company's disclosure on Sept. 11 that director Morris Milton Mayo bought 15K shares in the company at $1.06 on Sept

Chg %. $3.76. -0.16. -4.08%. Myomo Inc. advanced stock charts by MarketWatch. View MYO historial stock data and compare to other stocks and exchanges.

Find the latest Myomo, Inc. (MYO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Myomo's market capitalization of $137.35M, combined with a high stock momentum (+766.22% over a year vs SPY's +21.14%), suggests strong market confidence. Data by YChartsEmail Alerts. Receive SEC Filings, Events & Presentations, News Releases and Stock Price Alerts. Myomo, Inc. is a medical robotics company that offers expanded mobility for those suffering from neurological...Annual Report 2022. Annual Report 2021. Annual Report 2021. Annual Report 2020. Annual Report 2020. Annual Report 2019. Annual Report 2019. Results and Presentations.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...See the company profile for Myomo, Inc. (MYO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Dec 31, 2016 · Paul Gudonis. myomo.com. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient ... Get a real-time Myomo, Inc. (MYO) stock price quote with breaking news, financials, statistics, charts and more.NYSE:MYO Myomo, Inc. (NYSE:MYO) specializes in wearable medical robotics, focusing on improving arm and hand function for people with neurological disorders or upper-limb paralysis. The company ... Myomo stock has received a consensus rating of buy. The average rating score is and is based on 2 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Myomo stock?

Photo studios.

Next door application.

Stock Price Forecast. The 2 analysts with 12-month price forecasts for Myomo stock have an average target of 4.25, with a low estimate of 2.00 and a high estimate of 6.50. The average target predicts an increase of 13.03% from the current stock price of 3.76.Myomo Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MYO updated stock price target summary.myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform ...Myomo Announces $6M Registered Direct Offering Of 1,578,948 Shares Of Common Stock At $3.80/Share. Benzinga Newsdesk - Jan 17, 2024, 8:06AM.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig... Myomo stock has received a consensus rating of buy. The average rating score is and is based on 2 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Myomo stock? CAMBRIDGE, Mass., February 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at an offering ...Find the latest dividend history for Myomo Inc. Common Stock (MYO) at Nasdaq.com.Myomo, Inc. (NYSE American: MYO) reports Q4 total revenue of $4.8 million, up 18% from the prior year. The addition of Medicare Part B patients leads to a record 183 MyoPro orders, up 87%. ... Preferred stock — — Common stock 2,715 775 Additional paid-in capital 105,840,239 95,105,071 Accumulated other comprehensive income 83,669 ...BOSTON, November 07, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from ...Momo stock price target cut to $27 from $34 at Benchmark. Sep. 4, 2020 at 6:08 a.m. ET by Tomi Kilgore. ….

MYO stock results show that Myomo missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 7 Stock Winners That Are Up 1,000% or More in 2023.Unexchanged or unsurrendered stocks are those shares that should have changed hands but have not. When a share goes unexchanged, it is typically the fault of the company issuing th...Jun 14, 2021 · Myomo Inc. (NYSE:MYO) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for MYO is 51.7. Stocks with higher number ... You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers …Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its "best efforts" public offering of 20,000,000 shares of common stock (or common stock … Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock trading and investing.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Jan. 17. MT. Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023. Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up … Myomo stock, Myomo, Inc. (MYO) delivered earnings and revenue surprises of -40% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?, Get a real-time Myomo, Inc. (MYO) stock price quote with breaking news, financials, statistics, charts and more., The MyoPro Brace for Stroke Survivor's Paralyzed Arm. MyoPro is a powered arm and hand orthosis (brace) designed to help restore function to the wearer’s paralyzed or weakened upper extremities, helping individuals perform actions and daily activities that might otherwise be impossible. The MyoPro may also facilitate rehabilitation including ..., Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services (CMS) published a final rule classifying the MyoPro under the brace benefit category., Myomo, Inc. (MYO) delivered earnings and revenue surprises of -40% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?, May 10, 2024 · What is Myomo's stock price target for 2024? 2 brokerages have issued 1-year price targets for Myomo's stock. Their MYO share price targets range from $6.50 to $6.50. On average, they expect the company's share price to reach $6.50 in the next year. This suggests a possible upside of 70.6% from the stock's current price. , Find the latest Myomo, Inc. (MYO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors., Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market Read More > January 17, 2024 Myomo Reports Preliminary Fourth Quarter Revenue and Backlog Read More > January 17, 2024 ... Myomo, Inc. is the owner of registered trademarks Myomo and MyoPro., See the company profile for Myomo, Inc. (MYO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ..., Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you..., If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t..., The stock photos that come with your Chromecast are beautiful and all, but if you want to switch things up, you can customize it a bit more to your liking. All you need is the Goog..., For Myomo: [email protected] Investor Relations: Kim Sutton Golodetz LHA Investor Relations [email protected] 212-838-3777 Source: Myomo, Inc. Analyze your stocks, your way, Jan. 17. MT. Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023. Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up …, See the company profile for Myomo, Inc. (MYO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ..., See Myomo, Inc. (MYO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades., View Myomo, Inc. MYO stock quote prices, financial information, real-time forecasts, and company news from CNN. ... Myomo, Inc. is a wearable medical robotics company, which engages in the ... , 52 Week Low Date 05/19/23. Market Cap 104.254M. Shares Out 28.80M. 10 Day Average Volume 0.36M. Dividend -. Dividend Yield -. Beta 1.47. YTD % Change -27.35., The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used to help inform investors when researching potential investment opportunities. Myomo Inc ..., View Myomo, Inc. MYO stock quote prices, financial information, real-time forecasts, and company news from CNN. ... Myomo, Inc. is a wearable medical robotics company, which engages in the ... , Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. BOSTON, January 19, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a ..., May 8, 2024 1:05pm. Myomo Reports First Quarter 2024 Financial Results. Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year. Record 493 MyoPro ..., Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. Volume reflects consolidated markets. Futures and Forex: 10 or 15 minute delay, CT. Market Data powered ..., According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe..., View the real-time Myomo Inc (NYSE MYO) share price. Assess historical data, charts, technical analysis and contribute in the forum., Myomo is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Learn more about the MyoPro product line of lightweight, non-invasive, powered arm braces that can restore function and independence for people with impaired arms and hands., Cambridge, Mass.–based Myomo’s common stock is slated to begin trading on a split-adjusted basis when the markets open tomorrow, and it will continue to trade on the NYSE American market under ..., BOSTON, February 29, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from ..., 1D Views Studies Export. This is an example of a complex marker which can contain html, video, images, css, and animations. Interactive stock price chart for Myomo, Inc. (MYO) with real-time updates, full price history, technical analysis and more., View Myomo, Inc. MYO stock quote prices, financial information, real-time forecasts, and company news from CNN. ... Myomo, Inc. is a wearable medical robotics company, which engages in the ..., Get Myomo Inc (MYO) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments, Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market 01-17 - 2 views Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations Q3 total revenue of $5.1 million, up 28% over the prior year 156 MyoPro orders and insurance authorizations received, including the ..., Myomo ( NYSEMKT: MYO) is owned by 33.21% institutional shareholders, 11.64% Myomo insiders, and 55.15% retail investors. Paul R. Gudonis is the largest individual Myomo shareholder, owning 878,245.00 shares representing 3.08% of the company. Paul R. Gudonis's Myomo shares are currently valued at $3.01M. If you're new to stock …